The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy
Abstract
Evidence implicates hyperglycemia-derived oxygen free radicals as mediators of diabetic complications. However, intervention studies with classic antioxidants, such as vitamin E, failed to demonstrate any beneficial effect. Recent studies demonstrate that a single hyperglycemia-induced process of overproduction of superoxide by the mitochondrial electron-transport chain seems to be the first and key event in the activation of all other pathways involved in the pathogenesis of diabetic complications. These include increased polyol pathway flux, increased advanced glycosylation end product formation, activation of protein kinase C, and increased hexosamine pathway flux. Superoxide overproduction is accompanied by increased nitric oxide generation, due to an endothelial NOS and inducible NOS uncoupled state, a phenomenon favoring the formation of the strong oxidant peroxynitrite, which in turn damages DNA. DNA damage is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP-ribose) polymerase. Poly(ADP-ribose) polymerase activation in turn depletes the intracellular concentration of its substrate NAD+, slowing the rate of glycolysis, electron transport, and ATP formation, and produces an ADP-ribosylation of the GAPDH. These processes result in acute endothelial dysfunction in diabetic blood vessels that, convincingly, also contributes to the development of diabetic complications. These new findings may explain why classic antioxidants, such as vitamin E, which work by scavenging already-formed toxic oxidation products, have failed to show beneficial effects on diabetic complications and may suggest new and attractive “causal” antioxidant therapy. New low–molecular mass compounds that act as SOD or catalase mimetics or l-propionyl-carnitine and lipoic acid, which work as intracellular superoxide scavengers, improving mitochondrial function and reducing DNA damage, may be good candidates for such a strategy, and preliminary studies support this hypothesis. This “causal” therapy would also be associated with other promising tools such as LY 333531, PJ34, and FP15, which block the protein kinase β isoform, poly(ADP-ribose) polymerase, and peroxynitrite, respectively. While waiting for these focused tools, we may have other options: thiazolinediones, statins, ACE inhibitors, and angiotensin 1 inhibitors can reduce intracellular oxidative stress generation, and it has been suggested that many of their beneficial effects, even in diabetic patients, are due to this property.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanisms underlying the biological effects of statins and AT-1 receptor blockers differ, even in terms of intracellular antioxidant activity.”
In the citing paper
“Statins and AT-1 receptor blockers protect endothelial function and reduce inflammation in diabetic and nondiabetic subjects, and these effects are convincingly mediated through their intracellular antioxidant activity.”
In the citing paper
“Although this review is concerned with mitochondrial ROS, it should be recognized that considerable ROS derives from outside this organelle, including oxygen radicals from peroxisomal β-oxidation of fatty acids (24), NAD(P)H oxidase (53), xanthine oxidase, arachidonic acid metabolism, microsomal P-450 enzymes (75), and the prooxidant heme molecule (226).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [53]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Cited by
Sorted by citations
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Ceriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378
Self-citationDiabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-5 · Cited by 1,024
Postprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945
Self-citationSivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
Biomarkers of Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus
Meigs, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1978 · Cited by 643
The Molecular Basis for Oxidative Stress-Induced Insulin Resistance
Evans, J. L., Maddux, B. A., & Goldfine, I. D. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1040 · Cited by 587
The Role of Oxidative Stress in Diabetic Complications
Niedowicz, D. M., & Daleke, D. L. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:2:289 · Cited by 533
The Significance of Vascular and Neural Apoptosis to the Pathology of Diabetic Retinopathy
Barber, A. J., Gardner, T. W., & Abcouwer, S. F. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6293 · Cited by 446
Ceriello, A., Ihnat, M. A., & Thorpe, J. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1824 · Cited by 420
Self-citationPathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
Yan, L. (2014) · Journal of Diabetes Research · doi:10.1155/2014/137919 · Cited by 425
Antioxidant and free radical scavenging potential of Achillea santolina extracts
Ardestani, A. D., & Yazdanparast, R. (2006) · Food Chemistry · doi:10.1016/j.foodchem.2006.10.066 · Cited by 391
Bakırel, T., Bakırel, U., Üstüner, O., Ülgen, S., & Yardibi, H. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.10.039 · Cited by 390
Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice
BarathManiKanth, S., Kalishwaralal, K., Sriram, M. I., Pandian, S. R. K., Youn, H., Eom, S.-H., & Gurunathan, S. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-16 · Cited by 392
Lipid Peroxidation in Diabetes Mellitus
Davı̀, G., Falco, A., & Patrono, C. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.256 · Cited by 378
Ceriello, A., Quagliaro, L., Piconi, L., Assaloni, R., Da Ros, R., Maier, A., Esposito, K., & Giugliano, D. (2004) · Diabetes · doi:10.2337/diabetes.53.3.701 · Cited by 362
Self-citationKitada, M., Kume, S., Imaizumi, N., & Koya, D. (2011) · Diabetes · doi:10.2337/db10-0386 · Cited by 345
Evaluation of a New Measure of Blood Glucose Variability in Diabetes
Kovatchev, B. P., Otto, E., Cox, D. J., Gonder-Frederick, L. A., & Clarke, W. L. (2006) · Diabetes Care · doi:10.2337/dc06-1085 · Cited by 344
Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2022) · Molecules · doi:10.3390/molecules27030950 · Cited by 354
Pacher, P., Obrosova, I. G., Mabley, J. G., & Szabó, C. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363207 · Cited by 335
Piconi, L., Quagliaro, L., Assaloni, R., ROS, R. D., Maier, A., Zuodar, G., & Ceriello, A. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.613 · Cited by 332
Self-citationOxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives
Madsen‐Bouterse, S. A., & Kowluru, R. A. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9090-4 · Cited by 307
Ceriello, A., Assaloni, R., Da Ros, R., Maier, A., Piconi, L., Quagliaro, L., Esposito, K., & Giugliano, D. (2005) · Circulation · doi:10.1161/01.cir.0000165070.46111.9f · Cited by 298
Self-citationBensellam, M., Laybutt, D. R., & Jonas, J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.003 · Cited by 304
Ramalho-Santos, J., Amaral, S., & Oliveira, P. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502398 · Cited by 359
Piconi, L., Quagliaro, L., & Ceriello, A. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.177 · Cited by 256
Self-citationAdvanced glycation endproducts (AGEs): pharmacological inhibition in diabetes
Peyroux, J., & Sternberg, M. (2006) · Pathologie Biologie · doi:10.1016/j.patbio.2006.07.006 · Cited by 250
Balasubramanyam, M., Koteswari, A. A., Kumar, R. S., Monickaraj, S. F., Maheswari, J. U., & Mohan, V. (2003) · Journal of Biosciences · doi:10.1007/bf02708432 · Cited by 243
Patel, T. P., Rawal, K., Bagchi, A. K., Akolkar, G., Bernardes, N., Dias, D. D. S., Gupta, S. S., & Singal, P. K. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9515-6 · Cited by 243
Nitrosative stress and pharmacological modulation of heart failure
Pacher, P., Schulz, R., Liaudet, L., & Szabó, C. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.003 · Cited by 237
Carlström, M., & Larsson, S. C. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy014 · Cited by 248
Diabetic nephropathy: Is there a role for oxidative stress?
Sagoo, M. K., & Gnudi, L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.040 · Cited by 237
The Keap1-Nrf2 system and diabetes mellitus
Uruno, A., Yagishita, Y., & Yamamoto, M. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.12.012 · Cited by 231
Possible role of oxidative stress in the pathogenesis of hypertension
Ceriello, A. (2008) · Diabetes Care · doi:10.2337/dc08-s245 · Cited by 215
Self-citationTherapeutic Applications of Rose Hips from Different Rosa Species
Mármol, I., Sánchez‐de‐Diego, C., Jiménez‐Moreno, N., Ancín‐Azpilicueta, C., & Rodriguez‐Yoldi, M. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061137 · Cited by 221
Yoh, K., Hirayama, A., Ishizaki, K., Yamada, A., Takeuchi, M., Yamagishi, S., Morito, N., Nakano, T., Ojima, M., Shimohata, H., et al. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01234.x · Cited by 207
Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
Matzinger, M., Fischhuber, K., & Heiß, E. H. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.015 · Cited by 208
Tucker, P. S., Scanlan, A. T., & Dalbo, V. J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/806358 · Cited by 208
Cai, L., Wang, J., Li, Y., Sun, X., Wang, L., Zhou, Z., & Kang, Y. J. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1829 · Cited by 199
Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis
Nishikawa, M., Hashida, M., & Takakura, Y. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.01.001 · Cited by 200
Intervention against the Maillard reaction in vivo
Monnier, V. M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.014 · Cited by 196
Diabetic nephropathy and antioxidants
Tavafi, M. (2013) · Journal of Nephropathology · doi:10.5812/nephropathol.9093 · Cited by 195
Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
Ceriello, A., & Testa, R. (2009) · Diabetes Care · doi:10.2337/dc09-s316 · Cited by 200
Self-citationUsharani, P., Mateen, A., Naidu, M. U. R., Raju, Y. S. N., & Chandra, N. (2008) · Drugs in R&D · doi:10.2165/00126839-200809040-00004 · Cited by 200
Mitochondria, Synaptic Plasticity, And Schizophrenia
Ben‐Shachar, D., & Laifenfeld, D. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59011-6 · Cited by 191
Clarke, R., Dordevic, A. L., Tan, S. M., Ryan, L., & Coughlan, M. T. (2016) · Nutrients · doi:10.3390/nu8030125 · Cited by 186
Pacher, P., & Szabó, C. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1568 · Cited by 183
Postprandial hyperglycemia as an etiological factor in vascular failure
Node, K., & Inoue, T. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-23 · Cited by 183
The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy
Sifuentes-Franco, S., Pacheco-Moisés, F. P., Rodríguez-Carrizález, A. D., & Miranda‐Díaz, A. G. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1673081 · Cited by 186
Houghton, C. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2716870 · Cited by 191
Mild hypoglycemia is independently associated with increased mortality in the critically ill
Krinsley, J. S., Schultz, M. J., Spronk, P. E., Harmsen, R. E., Houckgeest, F. V. B., van der Sluijs, J. P., Mélot, C., & Preiser, J. (2011) · Critical Care · doi:10.1186/cc10322 · Cited by 181
Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes
Pacher, P., & Szabó, C. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.01.001 · Cited by 177
The emerging challenge in diabetes: The “metabolic memory”
Ceriello, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.05.005 · Cited by 177
Self-citationMehta, J. L., Rasouli, N., Sinha, A. K., & Molavi, B. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.008 · Cited by 169
Hypothesis: the ‘metabolic memory’, the new challenge of diabetes
Ihnat, M. A., Thorpe, J. E., & Ceriello, A. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02138.x · Cited by 169
Self-citationPostprandial glucose regulation: New data andnew implications
Leiter, L. A., Ceriello, A., Davidson, J. A., Hanefeld, M., Monnier, L., Owens, D. R., Tajima, N., & Tuomilehto, J. O. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.11.020 · Cited by 160
Self-citationWenzel, U., Nickel, A. G., & Daniel, H. (2005) · APOPTOSIS · doi:10.1007/s10495-005-0810-x · Cited by 159
Oak, J., & Cai, H. “. (2006) · Diabetes · doi:10.2337/db06-0288 · Cited by 157
Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update
Ceriello, A., Davidson, J., Hanefeld, M., Leiter, L. A., Monnier, L., Owens, D. R., Tajima, N., & Tuomilehto, J. O. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.05.006 · Cited by 155
Self-citationEvaluation of oxidative stress markers in pathogenesis of diabetic neuropathy
Kasznicki, J., Kosmalski, M., Śliwińska, A., Mrowicka, M., Stańczyk, M. B., Majsterek, I., & Drzewoski, J. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1722-9 · Cited by 146
The research and development on the antioxidants in prevention of diabetic complications
Rahimi‐Madiseh, M., Malekpour-Tehrani, A., Bahmani, M., & Rafieian‐Kopaei, M. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.07.001 · Cited by 145
Erythritol is a sweet antioxidant
den Hartog, G. J. M., Boots, A. W., Adam‐Perrot, A., Brouns, F. J. P. H., Verkooijen, I., Weseler, A. R., Haenen, G. R. M. M., & Bast, A. (2009) · Nutrition · doi:10.1016/j.nut.2009.05.004 · Cited by 140
Boukhris, M., Bouaziz, M. A., Feki, I., Jemai, H., Feki, A. E., & Sayadi, S. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-81 · Cited by 138
Teixeira‐Lemos, E., de Oliveira, J. B. F., Pinheiro, J. P., & Reis, F. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/741545 · Cited by 136
Katavetin, P., Miyata, T., Inagi, R., Tanaka, T., Sassa, R., Ingelfinger, J. R., Fujita, T., & Nangaku, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090918 · Cited by 135
Horvath, E. M., Benkő, R., Kiss, L., Murányi, M., Pék, T., Fekete, K., Bárány, T., Somlai, Á., Csordás, A., & Szabó, C. (2009) · Diabetologia · doi:10.1007/s00125-009-1304-0 · Cited by 132
Endothelial Dysfunction in Diabetes Mellitus: Possible Involvement of Endoplasmic Reticulum Stress?
Basha, B. M., Samuel, S. M., Triggle, C. R., & Ding, H. (2012) · Experimental Diabetes Research · doi:10.1155/2012/481840 · Cited by 131
Fisher‐Wellman, K. H., Bell, H. K., & Bloomer, R. J. (2008) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.1.7732 · Cited by 131
Fenercioğlu, A. K., Saler, T., Genç, E., Sabuncu, H., & Altuntaş, Y. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346565 · Cited by 130
Platelets Express Activated P2Y 12 Receptor in Patients With Diabetes Mellitus
Hu, L., Chang, L., Zhang, Y., Zhai, L., Zhang, S., Qi, Z., Yan, H., Yan, Y., Luo, X., Zhang, S., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026995 · Cited by 134
Adewole, S. O., & Ojewole, J. A. O. (2010) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v6i1.57071 · Cited by 135
Reactive Oxygen and Nitrogen Species in Pathogenesis of Vascular Complications of Diabetes
Son, S. M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.3.190 · Cited by 125
The role of nitric oxide in inflammation and oxidative stress
Papi, S., Ahmadizar, F., & Hasanvand, A. (2019) · Immunopathologia Persa · doi:10.15171/ipp.2019.08 · Cited by 126
Late Stage Complications of Diabetes and Insulin Resistance
Soumya, D., & Srilatha, B. (2011) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000167 · Cited by 123
Schaffer, S. W., Jong, C. J., & Mozaffari, M. S. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.03.005 · Cited by 125
Duan, J., Guan, Y., Mu, F., Guo, C., Zhang, E., Yin, Y., Wei, G., Zhu, Y., Cui, J., Cao, J., et al. (2017) · Scientific Reports · doi:10.1038/srep41491 · Cited by 124
Ceriello, A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.11.020 · Cited by 124
Self-citationHomayouni, F., Haidari, F., Hedayati, M., Zakerkish, M., & Angali, K. A. (2018) · Phytotherapy Research · doi:10.1002/ptr.6046 · Cited by 126
Hypothesis: the “metabolic memory”, the new challenge of diabetes
Ceriello, A. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(09)70002-6 · Cited by 120
Self-citationZemestani, M., Rafraf, M., & Jafarabadi, M. A. (2015) · Nutrition · doi:10.1016/j.nut.2015.07.011 · Cited by 115
Nicolson, G. L., & Ash, M. E. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.11.010 · Cited by 117
Rashid, K., Chowdhury, S., Ghosh, S., & Sil, P. C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.009 · Cited by 115
Atkin, M., Laight, D. W., & Cummings, M. H. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.003 · Cited by 115
Pyridoxamine Traps Intermediates in Lipid Peroxidation Reactions in Vivo
Metz, T., Alderson, N. L., Chachich, M. E., Thorpe, S. R., & Baynes, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304292200 · Cited by 112
de Morais, H., de Souza, C. P., da Silva, L. M., Ferreira, D. M., Werner, M. F., Andreatini, R., da Cunha, J. M., & Zanoveli, J. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.011 · Cited by 111
Diabetic Cardiomyopathy and Its Prevention by Nrf2: Current Status
Chen, J., Zhang, Z., & Cai, L. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.5.337 · Cited by 112
Venkatachalam, K., Mummidi, S., Cortez, D. M., Prabhu, S. D., Valente, A. J., & Chandrasekar, B. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01363.2007 · Cited by 112
Clinical review: Oxygen as a signaling molecule
Bartz, R. R., & Piantadosi, C. A. (2010) · Critical Care · doi:10.1186/cc9185 · Cited by 116
Zheng, A., Li, H., Xu, J., Cao, K. J., Li, H., Pu, W., Yang, Z., Peng, Y., Long, J., Liu, J., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000884 · Cited by 108
Ceriello, A., Testa, R., & Genovese, S. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.01.006 · Cited by 106
Self-citationNicolson, G. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21247 · Cited by 108
Ceriello, A., Kumar, S., Piconi, L., Esposito, K., & Giugliano, D. (2007) · Diabetes Care · doi:10.2337/dc06-2048 · Cited by 105
Self-citationType 1 diabetes and cardiovascular disease
Schnell, O., Cappuccio, F. P., Genovese, S., Standl, E., Valensi, P. E., & Ceriello, A. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-156 · Cited by 110
Self-citationStructural changes in the myocardium during diabetes-induced cardiomyopathy
Adeghate, E. A., & Singh, J. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9388-5 · Cited by 104
Tsuneki, H., Sekizaki, N., Suzuki, T., Kobayashi, S., Wada, T., Okamoto, T., Kimura, I., & Sasaoka, T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.006 · Cited by 104
Broedbaek, K., Siersma, V., Henriksen, T., Weimann, A., Petersen, M. A., Andersen, J. T., Jimenez‐Solem, E., Stovgaard, E. S., Hansen, L. J., Henriksen, J. E., et al. (2011) · Diabetes Care · doi:10.2337/dc11-1620 · Cited by 104
Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes
Panigrahy, S. K., Bhatt, R., & Kumar, A. (2017) · Journal of Drug Targeting · doi:10.1080/1061186x.2016.1207650 · Cited by 103
Xia, Z., Kuo, K., Nagareddy, P. R., Wang, F., Guo, Z., Guo, T., Jiang, J., & McNeill, J. H. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.033 · Cited by 102
Ceriello, A., Cosmo, S. D., Rossi, M. C., Lucisano, G., Genovese, S., Pontremoli, R., Fioretto, P., Giorda, C. B., Pacilli, A., Viazzi, F. C., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12976 · Cited by 100
Self-citation
Metadata
- Authors
- Ceriello, A.
- Affiliations
- University of Udine (IT)
- Corresponding author
- Ceriello, Antonio
- ORCID
- Ceriello, Antonio
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2003-05-01
- Volume
- 26
- Issue
- 5
- Pages
- 1589-1596
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2058550328
- Cited by
- 734
- References
- 102
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 16 · 2023: 15 · 2022: 16 · 2021: 24 · 2020: 13 · 2019: 27 · 2018: 34 · 2017: 41 · 2016: 33 · 2015: 34 · 2014: 46 · 2013: 49 · 2012: 50
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, diabetes complications, superoxide, mitochondrial electron transport chain, hyperglycemia, polyol pathway, advanced glycation end products, protein kinase C, hexosamine biosynthetic pathway, nitric oxide, peroxynitrite, DNA damage, poly(ADP-ribose) polymerase, NAD+ depletion, endothelial dysfunction, antioxidant therapy, superoxide dismutase mimetic, catalase mimetics, alpha-lipoic acid, PJ34, thiazolidinediones, statins, ACE inhibitors, angiotensin receptor blockers
- MeSH terms
- Antioxidants, Diabetes Mellitus, DNA Damage, Endothelium, Vascular, Humans, Hyperglycemia, Models, Biological, Oxidative Stress, Peroxynitrous Acid, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review